New Mutations Involved in Colistin Resistance in <named-content content-type="genus-species">Acinetobacter baumannii</named-content>
ABSTRACT Colistin is used as the “last resort” to treat infections caused by multidrug-resistant Acinetobacter baumannii, which is at the top of the World Health Organization’s list of the most dangerous bacterial species that threaten human health. Unfortunately, colistin resistance has emerged in...
Guardado en:
Autores principales: | Bingbing Sun, Haiyan Liu, Yu Jiang, Lei Shao, Sheng Yang, Daijie Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65316fb34dfe4f70aaea84a3b4a463a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant <named-content content-type="genus-species">Acinetobacter baumannii</named-content> Clinical Isolates
por: Vincent Trebosc, et al.
Publicado: (2019) -
¿Se debe revisar la determinación de la CIM de colistín en Acinetobacter baumannii?
por: Villanueva,Xabier, et al.
Publicado: (2017) -
Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia
por: Yun-Jeong Jeong, et al.
Publicado: (2021) -
Aminoglycoside Heteroresistance in <named-content content-type="genus-species">Acinetobacter baumannii</named-content> AB5075
por: Sarah E. Anderson, et al.
Publicado: (2018) -
The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in <named-content content-type="genus-species">Acinetobacter baumannii</named-content>
por: Fanny Huang, et al.
Publicado: (2020)